⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22906419 | 1.00 | ALDH1A1 (0.47) | — | |
| SCHEMBL20963029 | 1.00 | ALDH1A1 (0.47) | — | |
| SCHEMBL12807926 | 1.00 | ALDH1A1 (0.47) | — | |
| SCHEMBL18909797 | 1.00 | ALDH1A1 (0.47) | — | |
| Hydrochloric Acid SCHEMBL7345601 | 0.97 | ALDH1A1 (0.45) | — | |
| SCHEMBL13440487 | 0.97 | — | — | |
| SCHEMBL17256488 | 0.90 | — | — | |
| Hydrochloric Acid SCHEMBL27988384 | 0.88 | — | — | |
| Alcohol SCHEMBL17743422 | 0.84 | EPHX1 (0.35) | — | |
| SCHEMBL10667304 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118203703-A | Material and method for producing scaffolds for receiving cells | 朗格生物技术公共公益股份有限公司 | 2024-06-18 | — | — | CN | claimed |
| CN-112703020-B | Material and method for producing scaffolds for receiving cells | 朗格生物技术公共公益股份有限公司 | 2024-04-16 | — | — | CN | claimed |
| CN-113563250-A | Benzoic acid tryptamine derivative and preparation and application thereof | 南华大学 | 2021-10-29 | — | — | CN | claimed |
| CN-112703020-A | Materials and methods for producing scaffolds to receive cells | 朗格生物技术公共公益股份有限公司 | 2021-04-23 | — | — | CN | claimed |
| CN-118203703-A | Material and method for producing scaffolds for receiving cells | 朗格生物技术公共公益股份有限公司 | 2024-06-18 | — | — | CN | disclosed |
| CN-112703020-B | Material and method for producing scaffolds for receiving cells | 朗格生物技术公共公益股份有限公司 | 2024-04-16 | — | — | CN | disclosed |
| US-20230303526-A1 | IRAK DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2023-09-28 | — | — | US | disclosed |
| WO-2020120539-A1 | NEW PYRROLIDINE-2-CARBOXYLIC ACID DERIVATIVES FOR TREATING PAIN AND PAIN RELATED CONDITIONS | ESTEVE PHARMACEUTICALS, S.A. (ES) | 2020-06-18 | — | — | WO | disclosed |
| EP-2040820-B1 | FILTERING FOR A SEMICONDUCTOR PROCESSING TOOL | ENTEGRIS INC (US) | 2019-03-27 | — | — | EP | disclosed |
| CN-104136435-B | bromodomain inhibitors | 艾伯维公司 | 2017-05-10 | — | — | CN | disclosed |
| EP-2342283-B1 | A FUNCTIONALIZED CYANINE HAVING A SILANE LINKER ARM, A METHOD OF PREPARING THEREOF AND USES THEREOF | UNIV DEGLI STUDI TORINO (IT) | 2013-08-21 | — | — | EP | disclosed |
| EP-1846408-B1 | 5-MEMBERED ANNELATED HETEROCYCLIC PYRIMIDINES AS KINASE INHIBITORS | JANSSEN PHARMACEUTICA NV (BE) | 2013-03-20 | — | — | EP | disclosed |
| US-20090069298-A1 | Pyrazolo[1,5-A]Pyrimidine Compounds | TANABE SEIYAKU CO., LTD. (JP) | 2009-03-12 | — | — | US | disclosed |
| CN-101223178-A | Therapeutic agents | ASTRAZENECA AB (SE) | 2008-07-16 | — | — | CN | disclosed |
| WO-2008008497-A9 | FILTERING SYSTEM FOR A SEMICONDUCTOR PROCESSING TOOL | ENTEGRIS INC (US) | 2008-05-02 | — | — | WO | disclosed |
| WO-2008008497-A1 | FILTERING SYSTEM FOR A SEMICONDUCTOR PROCESSING TOOL | ENTEGRIS, INC. (US) | 2008-01-17 | — | — | WO | disclosed |
| WO-2007046548-A1 | PYRAZOLO[1,5-A]PYRIMIDINE COMPOUNDS AS CANNABINOID RECEPTOR ANTAGONISTS | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2007-04-26 | — | — | WO | disclosed |
| EP-1436287-A4 | SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION | CURIS INC (US) | 2005-10-26 | — | — | EP | disclosed |
| EP-1436287-A2 | SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION | Curis, Inc. (US) | 2004-07-14 | — | — | EP | disclosed |
| WO-2003027234-A2 | SMALL ORGANIC MOLECULE REGULATORS OF CELL PROLIFERATION | CURIS, INC. (US) | 2003-04-03 | — | — | WO | disclosed |